Ippokratio General Hospital Of Thessaloniki

At Ippokratio General Hospital Of Thessaloniki, the Ophthalmology Clinic is active in research on eye diseases such as glaucoma, ocular hypertension, and thyroid eye disease. These studies are focused on improving diagnosis, testing better treatment options, and evaluating how well therapies protect vision over time.

• Glaucoma and elevated intraocular pressure
• Ocular hypertension and vision preservation
• Thyroid eye disease and immune-related eye inflammation

The site also contributes to trials assessing whether new or improved eye treatments can offer reliable control of eye pressure and better long-term outcomes for patients.

A major part of the research portfolio covers skin and connective tissue diseases, especially atopic dermatitis, psoriasis, hidradenitis suppurativa, prurigo nodularis, and bullous pemphigoid. These trials are designed to test new therapies, improve symptom control, and understand long-term safety in chronic inflammatory skin conditions.

• Atopic dermatitis and persistent itching
• Psoriasis and plaque control
• Hidradenitis suppurativa and chronic skin inflammation

The research at this hospital often explores whether emerging treatments can reduce disease activity, relieve discomfort, and maintain benefits over time in patients with difficult-to-manage dermatologic conditions.

The site conducts studies in digestive system diseases and nutritional and metabolic diseases, with a strong focus on Crohn’s disease, ulcerative colitis, eosinophilic esophagitis, NASH, and non-alcoholic fatty liver disease. This work aims to improve treatment effectiveness, reduce inflammation, and support better long-term disease control.

• Inflammatory bowel disease, including Crohn’s disease and ulcerative colitis
• NASH and liver fibrosis
• Eosinophilic esophagitis and swallowing-related symptoms

Research in this area reflects a broad effort to find therapies that can slow disease progression, improve quality of life, and address chronic gastrointestinal and liver inflammation.

Clinical trials at Ippokratio General Hospital Of Thessaloniki also cover cardiovascular diseases, chronic kidney disease, heart failure, hypertension, and type 2 diabetes. These studies are aimed at evaluating treatments that may protect kidney function, improve heart outcomes, and better manage blood pressure and metabolic risk.

• Chronic kidney disease and proteinuria
• Heart failure and cardiovascular risk
• Hypertension and metabolic disease

The research landscape here includes efforts to test therapies that could delay organ damage, reduce complications, and support more effective long-term management of interconnected heart, kidney, and metabolic conditions.

Another active area involves bacterial infections, virus diseases, fungal infections, and serious hospital-based infections such as sepsis, pneumonia, and urinary tract infections. These trials are focused on improving treatment effectiveness, supporting faster infection control, and addressing difficult-to-treat pathogens.

• Sepsis and bloodstream infection
• Complicated urinary tract and intra-abdominal infections
• Invasive candidiasis and other fungal infections

The hospital contributes to research that helps refine infection treatment strategies, particularly for patients with severe illness or infections that require specialized care.

The site is also involved in trials for hemic and lymphatic diseases, congenital disorders, and other rare conditions, including thalassemia, hemophilia, sickle cell disease, and juvenile idiopathic arthritis. These studies often aim to improve disease control, reduce complications, and evaluate new approaches for long-term care.

• Thalassemia and anemia-related disorders
• Hemophilia and bleeding prevention
• Pediatric inflammatory and genetic diseases

This area of research highlights the hospital’s role in studying uncommon and complex diseases where better therapies can make a substantial difference for patients and families.